The collection of high-quality genomic DNA remains a major barrier in pediatric and neurodevelopmental research, particularly among children with autism spectrum disorder (ASD) and other neurogenetic ...

August 27, 2010 — In the war against the transmission of bloodborne pathogens such as hepatitis B virus, the US Centers for Disease Control and Prevention (CDC) and the US Food and Drug Administration ...

New evidence supports the use of continuous glucose monitoring as a means to help control glycated hemoglobin levels in people with type 1 diabetes (T1D). The study, which compared continuous ...

A world-first Australian trial has found that a simple fingerstick test for hepatitis B DNA is as accurate as standard lab testing, paving the way for wider access in remote and resource-limited ...

A novel test, based on biomarkers measured through a single drop of blood via a fingerstick, could give rapid results on radiation exposure levels, unlike current testing methods, which may take as ...

In a milestone for Americans with diabetes, the Food and Drug Administration (FDA) has cleared the first-ever continuous blood sugar monitoring device that doesn’t require patients to take potentially ...

A world-first Australian trial has found that a simple fingerstick test for hepatitis B DNA is as accurate as standard lab testing, paving the way for wider access in remote and resource-limited ...

FREMONT, Calif., June 02, 2026 (GLOBE NEWSWIRE) -- Alamar Biosciences, Inc. (Nasdaq: ALMR), a leader in precision proteomics dedicated to enabling the earliest detection of disease, today launched the ...

Fingerstick cardiac troponin I assay testing using thepoint-of-care i-STAT device is not accurate enough to determine the exact troponin level without the application of a corrective term. Fingerstick ...

Today, the U.S. Food and Drug Administration announced that an emergency use authorization (EUA) has been issued for a rapid, single-use test for the detection of Ebola virus (Zaire ebolavirus). This ...

Researchers have determined that fingerstick cardiac troponin I assay testing using thepoint-of-care i-STAT device is not accurate enough to determine the exact troponin level without the application ...